| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $25.2M | — | +33.7% |
| Cost of Revenue | $14.4M | — | +23.5% |
| Gross Profit | $10.8M | — | +50.5% |
| R&D Expense | $2.6M | — | +22.2% |
| SG&A Expense | $6.1M | — | +19.9% |
| Operating Income | -$2.4M | — | +39.4% |
| Pre-tax Income | -$1.9M | — | +71.5% |
| Income Tax | -$164K | — | -155.4% |
| Net Income | -$1.8M | — | +75.0% |
| EPS (Basic) | -$0.02 | — | +81.8% |
| EPS (Diluted) | -$0.02 | — | +81.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $11.6M | +50.9% | +36.1% |
| Accounts Receivable | $14.2M | +2.0% | +36.6% |
| Inventory | $24.8M | -20.7% | +31.2% |
| Current Assets | $55.1M | -5.0% | +6.4% |
| Total Assets | $74.9M | -4.1% | +6.0% |
| Current Liabilities | $22.4M | -42.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.3M | — | -1645.7% |
| Capital Expenditures | $209K | — | — |
| Investing Cash Flow | -$209K | — | +94.1% |
| Financing Cash Flow | $13.4M | — | +1535.9% |
| Free Cash Flow | -$9.5M | — | — |
| -61.6% |
| Long-term Debt | $0 | — | -100.0% |
| Total Liabilities | $34.0M | -32.5% | -49.1% |
| Stockholders' Equity | $40.8M | +47.9% | +982.0% |